StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance CALA opened at $0.03 on Tuesday. The stock has a market capitalization of $146,100.00, a PE ratio of […]

Related Keywords

California ,United States ,South San Francisco ,Calithera Biosciences ,Calithera Biosciences Inc ,Vanguard Group Inc ,Renaissance Technologies ,Goldman Sachs Group Inc ,Affinity Asset Advisors ,Alyeska Investment Group ,Free Report ,Asset Advisors ,Sachs Group ,Vanguard Group ,Get Free Report ,Calithera Biosciences Daily ,Nasdaq Cala ,Ocala ,Medical ,Initiated Coverage ,Stocknews Com ,